Report Store Get Proposal

Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Home Blog Cardiovascular diseases 14

Cardiovascular Diseases

MedTech News and Updates for AbbVie and Baxter

Notizia - Recent Pharma, Healthcare and Biotech Happenings

AbbVie & iSTAR’S Strategic Alliance; Baxter Launches Welch Allyn RetinaVue 100 Imager PRO; Instylla’S Embrace Hydrogel Embolic System; Primary Endpoint Met in the RADIANCE II US Trial; Roche’s Elecsys Amyloid Plasma Panel; EU Approval to Seegene’s Allplex; SARS-CoV-2/FluA/FluB/RSV Assay

ReCor Medical and Otsuka Medical Devices Announce Primary Endpoint Met in the RADIANCE II US Pivotal Trial of the Paradise™ System for the Treatment of Hypertension On July 26, 2022, ReCor Medical, Inc., a completely owned subsidiary of Otsuka Medical Devices Co., Ltd., with its headquarters in Palo Alto, California, a firm dedicated to revolutionizing the treatment of hypertension and Otsuka Medical Devices Co., Ltd., a fully owned subsidiary of Otsuka Holdings Co., Ltd. announced that the RADIANCE II US FDA IDE pivotal trial evaluating the Paradise™ Ultrasound Renal Denervation (uRDN) System as a treatment for hypertension met its primary efficacy e...

Explore More...

Cardiovascular Disease

Cardiovascular Disease: A major cause of health loss and a global burden

Digital therapeutics

Potential of Digital therapeutics and increasing CVDs

Pharma News

Acceleron Pharma’s drug sotatercept touches the phase 2 mark; GT Medical receives nod for GammaTile; New treatment strategy for Parkinson’s disease

Pharma News

Tepezza receives approval; a new way to treat Alzheimer’s

polypills

Polypills: Can they offer a potential approach to treat CVDs?

Ischemia treatment market

Reversing Ischemia with Gene therapy

Pharma news

FDA approval to AZ’s Farxiga for heart failure; GSK divests two travel vaccines to Bavarian Nordic; New breakthrough therapy for Cystic Fibrosis

Systemic sclerosis

FDA approves Ofev for interstitial lung disease

Pharma News

Helsinn out licenses Pracinostat in South America

Pharma News

Juvenescence nets USD 100M; Sarepta DMD drug faces rejection

Recent Pharma News

Recursion Pharmaceuticals nets USD 121M; Bayer’s MRI agent gets a nod

Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension Therapies

Hypertension

World Hypertension day

NOTIZIA

Notizia

cystic fibrosis

Approach for Cystic Fibrosis; An alternative for Statins; Oral medications not safe; Carbon monoxide poisoning treatment gets approval

depression

Sage’s drug meets phase 3; Blocking 2 key pathways help in tackling TNBC; FDA clears Paragonix; FDA gives a nod

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly